The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex complicated chemical process. Preliminary routes focused on amino acid chain fragment coupling, utilizing https://keiranhcyg581423.webbuzzfeed.com/41048533/creation-and-research-implementations-of-retatrutide